Diabetic Macular Edema (DME) Completed Phase 3 Trials for Pegaptanib (DB04895)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01189461Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular EdemaTreatment